Table 2.
Clinical and Demographical Data of the second cohort of MS patients
| Total n | 171 |
|---|---|
| Age, mean (SD) | 42 (10) years |
| Women, n (%) | 111 (65) |
| Education, mean (SD) | 17 (3.6) years |
| Employment, n (%) | |
| Full time | 103 (61) |
| Part time | 30 (18) |
| Unemployed | 29 (17) |
| Retired due to disability | 8 (5) |
| Type of MS, n (%) | |
| RRMS | 133 (78) |
| PPMS | 11 (7) |
| SPMS | 11 (7) |
| CIS | 4 (2) |
| Unknown | 11 (7) |
| Disease Duration, mean (SD) | 9.2 (7) years |
| EDSS mean (range) | 1.86 (0–9) |
| Comorbidities, n (%) | |
| Smoking | 24 (14) |
| BMI > 30 | 24 (14) |
| Diabetes | 5 (3) |
| Hypertension | 14 (9) |
| Dyslipidaemia | 37 (24) |
| Other autoimmune disease | 24 (16) |
| Disease-Modifying Treatment, n (%) | |
| Injectable | 58 (34) |
| Oral | 73 (42) |
| Monoclonal Antibodies | 15 (9) |
| None | 21 (12) |
| Total number of pills or injections per patient per day, mean (SD) | 2.7 (2.1) |